Saratoga, CA, United States of America

Roger Fu

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 224(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Roger Fu: Innovator in Pharmaceutical Compositions

Introduction

Roger Fu, based in Saratoga, California, is a notable inventor in the field of pharmaceuticals, holding an impressive portfolio of 15 patents. His innovative contributions focus on improving the efficacy and consistency of drug formulations, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among Roger Fu's recent patents is a groundbreaking invention titled "Compositions with a rheological modifier to reduce dissolution variability." This patent details the development of extended-release compositions that provide a desirable pharmacokinetic profile while minimizing variability in dissolution samples, thus enhancing the reliability of drug release in patients. Another significant patent showcases his work on "Abuse-resistant oral dosage forms," which emphasizes the creation of oral dosage forms designed for the safe administration of pharmacologically active agents.

Career Highlights

Roger Fu contributes his talents to Durect Corporation, where he plays a vital role in the advancement of innovative pharmaceutical technologies. His extensive research and development efforts have positioned him as a leader in his field, making strides in creating formulations that address key challenges in drug delivery.

Collaborations

At Durect Corporation, Roger collaborates with talented coworkers, including Su Il Yum and Michael S. Zamloot. Together, they work to enhance the functionality and safety of pharmaceutical products, driving innovation through teamwork and shared expertise.

Conclusion

With a wealth of experience and a dedication to improving pharmaceutical compositions, Roger Fu continues to make significant contributions to the field. His innovative patents and collaborative efforts at Durect Corporation highlight the importance of advancements in drug formulations, ultimately benefiting patients and the broader healthcare community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…